GSK backs campaign for disclosure of trial dataBMJ 2013; 346 doi: https://doi.org/10.1136/bmj.f819 (Published 07 February 2013) Cite this as: BMJ 2013;346:f819
- Zosia Kmietowicz
The UK based pharmaceutical giant GlaxoSmithKline has become the first drug company to sign up to a campaign for all clinical trials to be registered and their full results disclosed.
The AllTrials initiative (alltrials.net) was set up in January by the charity Sense About Science, the BMJ, and other supporters of transparency in research.1 It is calling for registration of all clinical trials and for full study results and full clinical study reports (CSRs) to be made publicly available.
CSRs are formal study reports that provide more details on the design, methods, and results of clinical trials than published papers and …